In8Bio INAB
NASDAQ INAB
$1.40 +0.07 (+5.26%)
At close: Oct 1, 2026 · 4:00 PM EDT

In8Bio (INAB) Long-Term Debt Repayments (2021 - 2026)

Updated

In8Bio (INAB) reported Long-Term Debt Repayments of $62,000 for Q2 2026, down 73.5% from $234,000 a year earlier and down 42.1% from the prior quarter.

Analysis

In8Bio (INAB) Long-Term Debt Repayments (2021 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, In8Bio's Long-Term Debt Repayments came in at $403,000, down 54.8% year-over-year; for FY2025, it was $693,000, down 12.7% from FY2024.

  • Long-Term Debt Repayments has a four-year compound annual growth rate of 6.7% (FY2021 to FY2025).
  • By year, Long-Term Debt Repayments came in at $794,000 in FY2024 (-0.5%), $798,000 in FY2023 (+29.8%), $615,000 in FY2022 (+15.0%) and $535,000 in FY2021.
  • The Q2 2026 figure ranks as the lowest quarterly Long-Term Debt Repayments in data going back to Q1 2021.
  • Year over year, Long-Term Debt Repayments has now declined in each of the last four quarters, with an average decline of 18.3% over the last eight quarters.
  • The high point for year-over-year Long-Term Debt Repayments in five years was Q3 2023 (growth of 168.2%); the low point was Q2 2026 (a decline of 73.5%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $107,000 (Q1 2026), $111,000 (Q4 2025) and $123,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 2.00 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 5.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -2.45 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 17.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 In8Bio 25.89 Mn 25.89 Mn - 62,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 62,000.00
Mar 31, 2026 107,000.00
Dec 31, 2025 111,000.00
Sep 30, 2025 123,000.00
Jun 30, 2025 234,000.00
Mar 31, 2025 225,000.00
Dec 31, 2024 219,000.00
Sep 30, 2024 213,000.00
Jun 30, 2024 174,000.00
Mar 31, 2024 188,000.00
Dec 31, 2023 173,000.00
Sep 30, 2023 236,000.00
Jun 30, 2023 214,000.00
Mar 31, 2023 175,000.00
Dec 31, 2022 297,000.00
Sep 30, 2022 88,000.00
Jun 30, 2022 95,000.00
Mar 31, 2022 135,000.00
Dec 31, 2021 145,000.00
Sep 30, 2021 142,000.00
API Access

In8Bio Long-Term Debt Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=INAB&period=max&api_key=YOUR_API_KEY